II
LGND icon

Inspire Investing’s Ligand Pharmaceuticals LGND Stock Holding History

Inspire Investing’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$181K Buy
+909
New +$180K 0.01% 886
2025
Q4 		– Hold
0
– – – 1095
2022
Q2 		– Sell
-11,046
Closed -$775K – 779
2022
Q1 		$775K Buy
+11,046
New +$801K 0.09% 188
2021
Q1 		– Sell
-3,389
Closed -$210K – 676
2020
Q4 		$210K Buy
+3,389
New +$193K 0.05% 604
2020
Q3 		– Sell
-2,890
Closed -$202K – 510
2020
Q2 		$202K Sell
2,890
-1,557
-35% -$98.7K 0.07% 455
2020
Q1 		$202K Buy
+4,447
New +$252K 0.08% 426
2018
Q1 		– Sell
-678
Closed -$58K – 472
2017
Q4 		$58K Buy
+678
New +$58.8K 0.05% 398

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Inspire Investing's LGND Position: Q1 2026 in Review

Inspire Investing opened a new position in Ligand Pharmaceuticals (LGND) in Q1 2026: 909 shares worth $181K. The stake represents 0.01% of the portfolio and ranks #886 among its holdings. This is a return to the name: Inspire Investing previously reported a position in LGND as recently as Q1 2022.

Inspire Investing first reported a position in LGND in Q4 2017 and has held it in 6 quarters since. The position peaked at $775K in Q1 2022. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Inspire Investing held 909 shares of Ligand Pharmaceuticals worth $181K as of Q1 2026.
  • Ligand Pharmaceuticals was a new Inspire Investing position in Q1 2026.
  • Ligand Pharmaceuticals made up 0.01% of Inspire Investing's portfolio in Q1 2026, its #886 holding.
  • Inspire Investing first reported a position in Ligand Pharmaceuticals in Q4 2017 and has held it in 6 quarters since.
  • Inspire Investing's Ligand Pharmaceuticals position peaked at $775K in Q1 2022.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.